The next breakthrough in pharma may not come from a better molecule alone. It may come from better coordination.


 


The next breakthrough in pharma may not come from a better molecule alone. It may come from better coordination.

Drug development is an incredibly complex process. Scientific research, manufacturing, clinical trials, regulatory work, data analysis, and external partners all have to move together.

And when one part changes, the consequences can ripple across the entire program.

That's where the latest advances in AI are becoming particularly interesting.

AI is moving beyond simply helping researchers analyze biological and chemical questions. It's increasingly being designed to connect scientific insights with the operational workflows that turn those insights into medicines.

A recent example is Orchestra Bio, whose technology is designed to help biopharma teams track studies, identify downstream impacts when something changes, and surface potential next steps.

And now, OpenAI has acquired Orchestra Bio, bringing its team and technology into its life-sciences platform, Rosalind.

This is particularly interesting when viewed alongside OpenAI's recent work with Novo Nordisk and other pharmaceutical companies.

The direction is becoming clearer: AI in pharma isn't just about asking a model to analyze a molecule or summarize a research paper. It's moving toward AI systems that can reason across scientific data, connect different stages of development, and help teams navigate complex decisions.

That could mean:

:dna: AI assisting with biological and chemical research

:microscope: AI connecting researchers with scientific tools and data

:robot_face: AI agents monitoring development workflows and timelines

:link: AI helping teams understand how one decision can affect the next stage of a program

The goal isn't to replace scientists.

It's to reduce the enormous coordination burden around them by allowing researchers and development teams to spend more time on the decisions that require human expertise.

Considering that bringing a new medicine from target discovery to regulatory approval can take 10–15 years, even improvements in how these processes are coordinated could have significant consequences.

The bigger shift we're seeing is this:

AI is becoming part of the infrastructure of drug development, not just a tool used by researchers.

And that may prove to be one of the most important developments in AI-driven pharma.


#Pharma #Biotech #DrugDevelopment #DrugDiscovery #AI #LifeSciences #AIinHealthcare #Pharmaceuticals

Comments

Post a Comment

Popular posts from this blog

5 Skills to Work Better with AI

Image
  AI is everywhere, and it’s here to stay. From virtual assistants to powerful decision-making tools, AI is shaping the way we work and interact with technology. But simply using AI isn’t enough—you need to understand how to make the most of it. Many people, even in everyday interactions with AI-powered tools like ChatGPT, Gemini, or DeepSeek, struggle to get the results they expect. This isn’t because AI is flawed, but because working effectively with it requires a certain set of skills. Knowing how to phrase your queries, provide the right context, and interpret AI’s responses can make all the difference. Whether you use AI for work, creativity, or problem-solving, keeping these five key skills in mind will help you unlock its true potential. 1. Know Where to Use AI AI isn’t a one-size-fits-all solution. While it excels at processing vast amounts of data and analyzing lengthy documents, it’s not always necessary—or even useful—in every situation. It’s not a magic wand, and unders...
Read more

Part 1: Prompt engineering: The Art of Delegating to Generative AI

Image
Ever wondered why some people get spot-on, helpful responses from AI, while others end up with vague or confusing answers? It’s not just luck—it’s the power of good prompting. The way you ask the AI to do something matters—a lot. This is part one of a three-part series where we’ll explore what prompt engineering is and the different techniques you can use to guide AI effectively. Part two will cover the constituents of a prompt. In part thre, we’ll dive into how to create great prompts—with practical tips and examples to help you get the most out of AI. What is prompt engineering? So, what exactly is prompt engineering? It’s the art of telling an AI model what you want it to do. But why is it called an art—and yes, also a science? Because the way you frame your request can completely change the quality, accuracy, and usefulness of the response. To understand why prompting is such a big deal, you first need to know how these AI models actually work. The popular chat companions we’ve all...
Read more
Image
  GPU - The brain of Artificial Intelligence Machine Learning algorithms require tens and thousands of CPU based servers to train a model, which turns out to be an expensive activity. Machine Learning researchers and engineers are often faced with the problem of running their algorithms fast. Although initially invented for processing graphics in computer games, GPUs today are used in machine learning to perform feature detection from vast amount of unlabeled data. Compared to CPUs, GPUs take far less time to train models that perform classification and prediction. Characteristics of GPUs that make them ideal for machine learning Handle large datasets Needs far less data centre infrastructure Can be specialized for specific machine learning needs Perform vector computations faster than any known processor Designed to perform data parallel computation NVIDIA CUDA GPUs today are used to build deep learning image processing tools for  Adobe Creative Cloud. According to  NVID...
Read more